164 related articles for article (PubMed ID: 35015787)
1. Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
Zhang Y; Van Laer AO; Baicu CF; Neff LS; Hoffman S; Katz MR; Zeigler SM; Zile MR; Bradshaw AD
PLoS One; 2022; 17(1):e0262479. PubMed ID: 35015787
[TBL] [Abstract][Full Text] [Related]
2. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
4. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
6. Heart Rate-Induced Myocardial Ca
Silverman DN; Rambod M; Lustgarten DL; Lobel R; LeWinter MM; Meyer M
J Am Heart Assoc; 2020 Sep; 9(17):e017215. PubMed ID: 32856526
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
Friebel J; Weithauser A; Witkowski M; Rauch BH; Savvatis K; Dörner A; Tabaraie T; Kasner M; Moos V; Bösel D; Gotthardt M; Radke MH; Wegner M; Bobbert P; Lassner D; Tschöpe C; Schutheiss HP; Felix SB; Landmesser U; Rauch U
Eur Heart J; 2019 Oct; 40(40):3318-3332. PubMed ID: 31004144
[TBL] [Abstract][Full Text] [Related]
9. Heart Failure With Preserved Ejection Fraction in Hypertension Patients: A Myocardial MR Strain Study.
He J; Sirajuddin A; Li S; Zhuang B; Xu J; Zhou D; Wu W; Sun X; Fan X; Ji K; Chen L; Zhao S; Arai AE; Lu M
J Magn Reson Imaging; 2021 Feb; 53(2):527-539. PubMed ID: 32896042
[TBL] [Abstract][Full Text] [Related]
10. Unmasking of oestrogen-dependent changes in left ventricular structure and function in aged female rats: a potential model for pre-heart failure with preserved ejection fraction.
Bustamante M; Garate-Carrillo A; R Ito B; Garcia R; Carson N; Ceballos G; Ramirez-Sanchez I; Omens J; Villarreal F
J Physiol; 2019 Apr; 597(7):1805-1817. PubMed ID: 30681142
[TBL] [Abstract][Full Text] [Related]
11. Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction-Profibrotic and Proinflammatory Pathways and Genes.
Ye B; Bradshaw AD; Abrahante JE; Dragon JA; Häußler TN; Bell SP; Hirashima F; LeWinter M; Zile MR; Meyer M
Circ Heart Fail; 2023 Aug; 16(8):e010395. PubMed ID: 37582166
[TBL] [Abstract][Full Text] [Related]
12. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG
Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210
[TBL] [Abstract][Full Text] [Related]
14. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.
Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M
Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I
PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370
[TBL] [Abstract][Full Text] [Related]
16. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
17. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
18. Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a.
Shao S; Zhang Y; Gong M; Yang Q; Yuan M; Yuan M; Suo Y; Wang X; Li Y; Bao Q; Li G
Oxid Med Cell Longev; 2021; 2021():1257283. PubMed ID: 34630844
[TBL] [Abstract][Full Text] [Related]
19. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure.
López B; González A; Querejeta R; Larman M; Rábago G; Díez J
Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078
[TBL] [Abstract][Full Text] [Related]
20. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
